[
  {
    "date": "2023-12-30",
    "symbol": "SYRE",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2023-12-31",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-37722",
    "entityregistrantname": "SPYRE THERAPEUTICS, INC.",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "46-4312787",
    "entityaddressaddressline1": "221 Crescent Street",
    "entityaddressaddressline2": "Building 23, Suite 105",
    "entityaddresscityortown": "Waltham",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2453,
    "cityareacode": 617,
    "localphonenumber": "651-5940",
    "security12btitle": "Common Stock, $0.0001 Par Value Per Share",
    "tradingsymbol": "SYRE",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1636282,
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "auditorfirmid": 238,
    "auditorname": "PricewaterhouseCoopers LLP",
    "auditorlocation": "Austin, Texas",
    "cashandcashequivalentsatcarryingvalue": 188893000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 150384000,
    "prepaidexpenseandotherassetscurrent": 2251000,
    "assetscurrent": 341528000,
    "restrictedcashnoncurrent": 322000,
    "otherassetsnoncurrent": 9000,
    "assets": 341859000,
    "accountspayabletradecurrent": 896000,
    "derivativeliabilitiescurrent": 1390000,
    "accruedliabilitiesandotherliabilities": 13108000,
    "accountspayableothercurrent": 16584000,
    "liabilitiescurrent": 31978000,
    "derivativeliabilitiesnoncurrent": 41310000,
    "liabilities": 73288000,
    "temporaryequitycarryingamountattributabletoparent": 84555000,
    "preferredstockvalue": 184927000,
    "commonstockvalue": 10000,
    "additionalpaidincapitalcommonstock": 763191000,
    "accumulatedothercomprehensiveincomelossnetoftax": 302000,
    "retainedearningsaccumulateddeficit": -764414000,
    "stockholdersequity": 184016000,
    "liabilitiesandstockholdersequity": 341859000,
    "temporaryequityparorstatedvaluepershare": 0.0001,
    "temporaryequitysharesauthorized": 150000,
    "temporaryequitysharesissued": 150000,
    "temporaryequitysharesoutstanding": 150000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 1086341,
    "preferredstocksharesissued": 437037,
    "preferredstocksharesoutstanding": 437037,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 400000000,
    "commonstocksharesissued": 36057109,
    "commonstocksharesoutstanding": 36057109,
    "revenuefromcontractwithcustomerexcludingassessedtax": 886000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 89504000,
    "generalandadministrativeexpense": 39946000,
    "acquiredinprocessresearchanddevelopment": 130188000,
    "disposalgroupnotdiscontinuedoperationgainlossondisposal": 16449000,
    "operatingexpenses": 243189000,
    "operatingincomeloss": -242303000,
    "investmentincomenet": 6147000,
    "gainlossonderivativeinstrumentsnetpretax": -83530000,
    "othernonoperatingincomeexpense": -19130000,
    "nonoperatingincomeexpense": -96513000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -338816000,
    "incometaxexpensebenefit": -26000,
    "netincomeloss": -338790000,
    "earningspersharebasic": -49.12,
    "earningspersharediluted": -49.12,
    "weightedaveragenumberofsharesoutstandingbasic": 6897065,
    "weightedaveragenumberofdilutedsharesoutstanding": 6897065,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationgainlossarisingduringperiodnetoftax": 37000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 313000,
    "comprehensiveincomenetoftax": -338440000,
    "temporaryequitystockissuedduringperiodsharesnewissues": 150000,
    "temporaryequitystockissuedduringperiodvaluenewissues": 84555000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": -649000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": -202178000,
    "stockissuedduringperiodsharesnewissues": 721000,
    "stockissuedduringperiodvaluenewissues": 197364000,
    "stockissuedduringperiodsharesacquisitions": 365000,
    "stockissuedduringperiodvalueacquisitions": 189741000,
    "stockissuedduringperiodsharespurchaseofassets": 518000,
    "stockissuedduringperiodvaluepurchaseofassets": 1000,
    "stockissuedduringperiodsharesoptionsexercisedandemployeestockownershipplan": 48000,
    "stockissuedduringperiodvalueoptionsexercisedandemployeestockownershipplan": 405000,
    "contingentvaluerightdistributiontocommonstockholders": -29500000,
    "stockissuedduringperiodvaluesharebasedcompensation": 14347000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationstockoptionsrequisiteserviceperiodrecognition": 11471000,
    "depreciationdepletionandamortization": 744000,
    "sharebasedcompensation": 25675000,
    "assetimpairmentcharges": 2580000,
    "gainlossonsaleofpropertyplantequipment": -915000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 2318000,
    "operatingleaserightofuseassetamortizationexpense": 220000,
    "othernoncashincomeexpense": -15000,
    "increasedecreaseinaccountsreceivable": -375000,
    "increasedecreaseinaccountspayabletrade": 218000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -3245000,
    "increasedecreaseincontractwithcustomerliability": 575000,
    "increasedecreaseinoperatingleaseliability": -2326000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": -4891000,
    "increasedecreaseinotheraccountspayable": -2402000,
    "netcashprovidedbyusedinoperatingactivities": -99910000,
    "cashacquiredfromacquisition": 3035000,
    "proceedsfromsaleofintangibleassets": 15000000,
    "proceedsfromsaleofpropertyplantandequipment": 475000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 166803000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 39900000,
    "netcashprovidedbyusedininvestingactivities": -108393000,
    "proceedsfromissuanceofconvertiblepreferredstock": 197364000,
    "proceedsfromissuanceofprivateplacement": 84555000,
    "proceedsfromissuanceofcommonstock": 84555000,
    "paymentsforderivativeinstrumentfinancingactivities": 5786000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 405000,
    "financeleaseprincipalpayments": 16000,
    "netcashprovidedbyusedinfinancingactivities": 361077000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": 25000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 152799000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 189215000,
    "stockissued1": 189741000,
    "conversionofstockamountissued1": 202178000,
    "accruedandothercurrentliabilitiestextblock": "Accrued and Other Current Liabilities",
    "optionagreementtextblock": "Paragon Agreement",
    "scheduleofestimatedusefullivesofpropertyplantandequipmenttabletextblock": "The useful lives of the property and equipment are as follows:Laboratory equipment5 yearsFurniture and office equipment5 yearsComputer equipment3 yearsSoftware3 yearsLeasehold improvementsShorter of remaining lease term or estimated useful life",
    "scheduleofbalancesduetoaffiliatestabletextblock": "The following is the summary of Related party accounts payable and other current liabilities (in millions):December 31,2023December 31,2022Reimbursable costs under the Paragon Agreement$16.6 $— Related party accounts payable and other current liabilities$16.6 $—",
    "numberofoperatingsegments": 1,
    "cashcashequivalentsandshortterminvestments": 339300000,
    "numberofdomesticbankinginstitutions": 2,
    "cashfdicinsuredamount": 250000,
    "impairmentoflonglivedassetsheldforuse": 2600000,
    "impairmentlonglivedassetheldforusestatementofincomeorcomprehensiveincomeextensibleenumeration": "http://fasb.org/us-gaap/2023#GeneralAndAdministrativeExpense http://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
    "propertyplantandequipmentusefullife": "P5Y",
    "assetsfairvaluedisclosure": 150648000,
    "liabilitiesfairvaluedisclosure": 42700000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": -19000000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 42700000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitysettlements": 5786000,
    "derivativeliabilitymeasurementinput": 0.39,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilityissues": 29500000,
    "cashequivalentsatcarryingvalue": 150648000,
    "cashequivalentsunrealizedgains": 5000,
    "cashandcashequivalentsfairvaluedisclosure": 150648000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 79124000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 62000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 1000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlosspositionlessthan12months": 9907000,
    "debtsecuritiesavailableforsaleunrealizedlossposition": 9907000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlosspositionlessthan12monthsaccumulatedloss": 1000,
    "debtsecuritiesavailableforsaleunrealizedlosspositionaccumulatedloss": 1000,
    "debtsecuritiesavailableforsaleunrealizedgainloss": 300000,
    "debtsecuritiesavailableforsaleaccruedinterestafterallowanceforcreditloss": 900000,
    "debtsecuritiesavailableforsaleaccruedinterestafterallowanceforcreditlossstatementoffinancialpositionextensiblelistnotdisclosedflag": "Accrued interest receivable on available-for-sale debt securities",
    "availableforsalesecuritiesdebtmaturitieswithinoneyearfairvalue": 115784000,
    "availableforsalesecuritiesdebtmaturitiesafteronethroughfiveyearsfairvalue": 34600000,
    "accruedsalariescurrent": 4054000,
    "accruedcontractedresearchanddevelopmentcosts": 7092000,
    "accruedprofessionalfeescurrent": 1474000,
    "otheraccruedliabilitiescurrent": 488000,
    "minorityinterestownershippercentagebynoncontrollingowners": 0.05,
    "relatedpartytransactionnumberofboardseats": 2,
    "minorityinterestownershippercentagebynoncontrollingownersheldinthirdparty": 0.05,
    "relatedpartytransactionamountsoftransaction": 48500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 8776245,
    "allocatedsharebasedcompensationexpense": 100000,
    "relatedpartytransactionreimbursablecosts": 37100000,
    "licenseagreementmilestonepayments": 39500000,
    "lesseeoperatingleaserenewalterm": "P3Y",
    "operatingleasepayments": 500000,
    "financeleaserightofuseassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent",
    "financeleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities",
    "operatingleaseweightedaverageremainingleaseterm1": "P0Y",
    "financeleaseweightedaverageremainingleaseterm1": "P0Y",
    "operatingleasecost": 455000,
    "variableleasecost": 471000,
    "leasecost": 926000,
    "sharesauthorized": 410000000,
    "numberofcommonstockvotingrightsheldpershare": 1,
    "saleofstockpricepershare": 15,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 684407,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 21.52,
    "temporaryequityaggregateamountofredemptionrequirement": 129100000,
    "temporaryequityredemptionpricepershare": 21.52,
    "classofwarrantorrightoutstanding": 250000,
    "contractwithcustomerliabilityadditions": 575000,
    "contractwithcustomerliabilityincreasedecreaseforcontractacquiredinbusinesscombination": -3271000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingperiodincreasedecrease": 3029,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofadditionalsharesauthorized": 6000000,
    "commonstockcapitalsharesreservedforfutureissuance": 5019177,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 3294962,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 153865,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 9.67,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 477000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 64400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P3Y6M",
    "stockissuedduringperiodsharesstockoptionsexercised": 46246,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 637686,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 8497395,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1065700,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 12.13,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 9.67,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 8.22,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 43,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 12.13,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 24.72,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y7M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 98928000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 98928000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 13328000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 153865,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 5660,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 18.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 18.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 203.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y10M17D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0437,
    "definedcontributionplancostrecognized": 200000,
    "severancecosts1": 6400000,
    "paymentsforrestructuring": 5300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardacceleratedcompensationcost": 1000000,
    "restructuringreserve": 1123000,
    "restructuringcharges": 6448000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -338942000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 126000,
    "valuationallowancedeferredtaxassetchangeinamount": 17800000,
    "operatinglosscarryforwards": 354500000,
    "taxcreditcarryforwardamount": 21900000,
    "operatinglosscarryforwardssubjecttoexpiration": 58400000,
    "taxcreditcarryforwardssubjecttoexpiration": 21900000,
    "numberofdomesticsubsidiaries": 8,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -71151000,
    "effectiveincometaxratereconciliationforwardcontractliabilityamount": 17541000,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopment": 27340000,
    "effectiveincometaxratereconciliationcontingentvalueaddedliabilityamount": 3987000,
    "incometaxreconciliationchangeinenactedtaxrate": 4472000,
    "incometaxreconciliationtaxcostcredit": -1000,
    "incometaxreconciliationotheradjustments": -53000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 17839000,
    "deferredtaxassetsoperatinglosscarryforwards": 74454000,
    "deferredtaxassetscapitalizedresearchanddevelopmentcosts": 22532000,
    "deferredtaxassetsgoodwillandintangibleassets": 47000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 579000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 4246000,
    "deferredtaxassetstaxcreditcarryforwards": 21914000,
    "deferredtaxassetsother": 88000,
    "deferredtaxassetsgross": 125491000,
    "deferredtaxassetsvaluationallowance": 125491000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 2583226,
    "weightedaveragenumberofsharesissuedbasic": 6201954,
    "incrementalcommonsharesattributabletocalloptionsandwarrants": 695111
  }
]